Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase feasibility trial comparing oral ketamine to placebo for anxiety in patients with pancreatic cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Anxiety, Pancreatic Cancer | EARLY_Phase 1 | Status: RECRUITING